Table 4 Characteristics of Child-Pugh B and C decompensated cirrhosis patients

Sex (male / female)

18/2

13/6

n.s.

Mean age (years)

66 ± 8

67 ± 10

n.s.

Etiology (HBV / HCV / HBV + HCV / NBNC)

2/11/1/4

2/9/0/8

n.s.

Child-Pugh score (B / C)

12/8

13/6

n.s.

Hepatocellular carcinoma (absent / present)

10/10

12/7

n.s.

 Absent (none / after curative treatment)

5/5

8/4

 Present (Stage I / II / III / IV)

1/8/0/1

4/3/0/0

Esophageal varices (absent / present)

0/20

1/18

n.s.

Monotherapy / Combination therapy

8/12

11/8

n.s.

White blood cell count (/μL)

4177 ± 2631

3352 ± 1218

n.s.

Hemoglobin (g/dL)

11.2 ± 1.5

10.8 ± 2.0

n.s.

Platelet count (×10⁴/μL)

9.5 ± 7.7

7.2 ± 3.7

n.s.

Albumin (mg/dL)

2.9 ± 0.3

3.0 ± 0.4

n.s.

Total bilirubin (mg/dL)

1.9 ± 1.2

1.8 ± 1.2

n.s.

Aspartate aminotransferase (IU/L)

54 ± 35

44 ± 14

n.s.

Alanine aminotransferase (IU/L)

36 ± 28

29 ± 13

n.s.

Gamma-glutamyl transpeptidase (IU/L)

52 ± 58

51 ± 77

n.s.

Prothrombin time (%)

60 ± 10

63 ± 15

n.s.

Prothrombin time/International normalized ratio

1.3 ± 0.2

1.3 ± 0.2

n.s.

Fibrinogen degradation product (μg/mL)

16.5 ± 19.7

16.8 ± 11.6

n.s.

D-dimer (μg/mL)

8.4 ± 9.7

7.7 ± 5.7

n.s.

Antithrombin III (%)

53 ± 16

55 ± 19

n.s.